Company: NEOG
Filing Date: 2025-01-15
Form Type: 10-Q
Source: 0000950170-25-005818
Chunk: 25

Company: NEOGEN CORP
Filing Date: 2025-01-15
Form: 10-Q
Item: Item 1
Chunk 25
---
 not reflect the historical cash expenditures or future requirements for capital expenditures or contractual commitments; 

•they do not reflect any cash requirements for future replacements of assets that are being depreciated and amortized; and 

•they may be calculated differently from other companies in Neogen’s industries limiting their usefulness as comparative measures. 

A reader should compensate for these limitations by relying primarily on the financial statements of Neogen and using these non-GAAP financial measures only as a supplement to evaluate Neogen’s performance. 

For each of these non-GAAP financial measures below, we are providing a reconciliation of the differences between the non-GAAP measure and the most directly comparable GAAP measure. 

23

Reconciliation between net loss and EBITDA and Adjusted EBITDA and between net loss margin % and Adjusted EBITDA margin % are as follows: 

    Three months ended November 30,

    Six months ended November 30,

    2024

    2023

    2024

    2023

    Net loss
     
    $
    (456,282
    )
     
    $
    (3,487
    )
     
    $
    (468,891
    )
     
    $
    (1,984
    )

    Net loss margin %

    -197.3
    %

    -1.5
    %

    -104.6
    %

    -0.4
    %

    Income tax benefit

    (20,290
    )

    (260
    )

    (23,290
    )

    (100
    )

    Depreciation and amortization

    30,049

    29,469

    59,849

    58,203

    Interest expense, net

    17,367

    16,169

    34,989

    32,835

    EBITDA
     
    $
    (429,156
    )
     
    $
    41,891

    $
    (397,343
    )
     
    $
    88,954

    Share-based compensation

    4,819

    3,512

    8,801

    6,150

    FX transaction loss on loan and other revaluation (1)

    384

    1,002

    64

    712

    Certain transaction fees and integration costs (2)

    3,